KRRO Earnings & Financial Statements
Korro Bio, Inc.
$8.88
+$0.07(+0.79%)
38
Overall
60
Value
20
Tech
34
Quality
Market Cap
$130.76M
Volume
216.50K
52W Range
$5.20 - $55.89
Target Price
$20.00
KRRO earnings and financial statements: Korro Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
KRRO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.39M | $2.27M | - | - | $14.07M |
| Operating income | -$121.86M | -$91.91M | -$84.53M | -$59.00M | -$84.03M |
| EBITDA | -$112.34M | -$79.88M | -$77.52M | -$56.49M | -$33.90M |
| Net income | -$117.26M | -$83.58M | -$81.17M | -$58.03M | -$21.96M |
| EPS (diluted) | $-12.48 | $-9.37 | $-53.08 | - | $-123.50 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $113.51M | $226.24M | $221.66M | $73.74M | $185.36M |
| Total liabilities | $62.07M | $65.83M | $51.75M | $8.91M | $54.53M |
| Shareholders’ equity | $51.44M | $160.41M | $169.91M | -$99.03M | $130.82M |
| Cash and equivalents | $21.82M | $55.64M | $166.15M | $36.33M | $79.64M |
| Long-term debt | $40.81M | $43.48M | $31.22M | $209.0K | $43.02M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$78.56M | -$60.07M | -$67.28M | -$53.65M | -$32.09M |
| Capital expenditure | -$518.0K | -$17.90M | -$7.84M | -$5.21M | -$4.45M |
| Free cash flow | -$79.08M | -$77.98M | -$75.12M | -$58.86M | -$36.54M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRRO | $8.88 | +0.8% | 216.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |